AI
Tuesday, March 02, 2021 2:33:18 PM
Yes, I agree. It was that plus this current information that is now showing on UCLA's own website. The truth hurts, especially if it is not consistent with the false narrative they are trying to promote.
It is very telling that on this website page, UCLA lists the only 2 current immunotherapy treatment options currently available at UCLA for brain cancer as: DCVax-L & PD-1 inhibitors.
Especially, considering that the only current open clinical trial, that is currently recruiting at UCLA for recurrent Glioblastoma, is ATL-DC (DCVax-L) plus Pembrolizumab (Keytruda).
It is all so plain to see, unless you refuse to see it, as some Bears on this board have chosen not to see this.
https://www.uclahealth.org/braintumor/biologics
It is very telling that on this website page, UCLA lists the only 2 current immunotherapy treatment options currently available at UCLA for brain cancer as: DCVax-L & PD-1 inhibitors.
Especially, considering that the only current open clinical trial, that is currently recruiting at UCLA for recurrent Glioblastoma, is ATL-DC (DCVax-L) plus Pembrolizumab (Keytruda).
It is all so plain to see, unless you refuse to see it, as some Bears on this board have chosen not to see this.
https://www.uclahealth.org/braintumor/biologics
